MANKIND PHARMA
|
MANKIND PHARMA Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit Before Tax | ₹2,399 Cr | ₹1,671 Cr | ₹1,975 Cr | ₹1,692 Cr | ₹1,438 Cr |
Adjustment | ₹212 Cr | ₹298 Cr | ₹31 Cr | ₹-5.66 Cr | ₹105 Cr |
Changes In working Capital | ₹20 Cr | ₹167 Cr | ₹-586 Cr | ₹-95 Cr | ₹-140 Cr |
Cash Flow after changes in Working Capital | ₹2,632 Cr | ₹2,136 Cr | ₹1,419 Cr | ₹1,591 Cr | ₹1,403 Cr |
Cash Flow from Operating Activities | ₹2,152 Cr | ₹1,813 Cr | ₹920 Cr | ₹1,137 Cr | ₹1,072 Cr |
Cash Flow from Investing Activities | ₹-2,082 Cr | ₹-1,054 Cr | ₹-1,369 Cr | ₹-1,222 Cr | ₹-439 Cr |
Cash Flow from Financing Activities | ₹5.27 Cr | ₹-740 Cr | ₹605 Cr | ₹-7.81 Cr | ₹-527 Cr |
Net Cash Inflow / Outflow | ₹76 Cr | ₹19 Cr | ₹155 Cr | ₹-93 Cr | ₹106 Cr |
Opening Cash & Cash Equivalents | ₹305 Cr | ₹283 Cr | ₹127 Cr | ₹220 Cr | ₹116 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | ₹1.17 Cr | ₹2.32 Cr | ₹0.48 Cr | ₹0.38 Cr | ₹3.60 Cr |
Closing Cash & Cash Equivalent | ₹382 Cr | ₹305 Cr | ₹283 Cr | ₹127 Cr | ₹226 Cr |
Compare Cashflow Statement of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹97,109.4 Cr | 1.3% | 17.9% | 43.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹437,483.0 Cr | 0.4% | 5.1% | 64.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹136,472.0 Cr | 2.1% | 3.9% | 42.8% | Stock Analytics | |
CIPLA | ₹130,171.0 Cr | -2.1% | 3.7% | 30.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,298.0 Cr | -2.9% | -3.7% | 20.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹110,736.0 Cr | -1% | -13.6% | 81.7% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | 1.3% |
17.9% |
43.2% |
SENSEX | -1.4% |
3.3% |
25.2% |
You may also like the below Video Courses